HLX99 / Fosun Pharma - LARVOL DELTA

THE INVESTIGATIONAL NEW DRUG APPLICATION OF INNOVATIVE SMALL MOLECULAR HLX99 WAS APPROVED BY THE UNITED STATES FOOD AND DRUG ADMINISTRATION (FDA) (HKEXnews) - "The board of directors of the Company (the 'Board') is pleased to announce that, recently, the investigational new drug application of innovative small molecular HLX99 ('HLX99') independently developed by the Company was approved by the United States Food and Drug Administration (FDA). HLX99 is intended for the treatment of amyotrophic lateral sclerosis (ALS)."

IND • Amyotrophic Lateral Sclerosis